A conserved isoleucine in the binding pocket of RIG-I controls immune tolerance to mitochondrial RNA.

Agathe Grünewald, Martin Schlee, Matthias Geyer, Thomas Zillinger, Gunther Hartmann, Gregor Hagelueken, Eva Bartok, Katrin Paeschke, Janos Ludwig, Christine Schuberth-Wagner, Christina Wallerath, Ann Kristin de Regt, Steven Wolter, Charlotte Hunkler, Alexander Kirchhoff, Daniel Hilbig, David Fusshöller, Bastian Putschli, Karl Gatterdam, Felix Bender, Katrin Ciupka, Kanchan Anand

Journal: Nucleic acids research 2023;51(21):11893-11910

PMID: 37831086

Abstract

RIG-I is a cytosolic receptor of viral RNA essential for the immune response to numerous RNA viruses. Accordingly, RIG-I must sensitively detect viral RNA yet tolerate abundant self-RNA species. The basic binding cleft and an aromatic amino acid of the RIG-I C-terminal domain(CTD) mediate high-affinity recognition of 5'triphosphorylated and 5'base-paired RNA(dsRNA). Here, we found that, while 5'unmodified hydroxyl(OH)-dsRNA demonstrated residual activation potential, 5'-monophosphate(5'p)-termini, present on most cellular RNAs, prevented RIG-I activation. Determination of CTD/dsRNA co-crystal structures and mutant activation studies revealed that the evolutionarily conserved I875 within the CTD sterically inhibits 5'p-dsRNA binding. RIG-I(I875A) was activated by both synthetic 5'p-dsRNA and endogenous long dsRNA within the polyA-rich fraction of total cellular RNA. RIG-I(I875A) specifically interacted with long, polyA-bearing, mitochondrial(mt) RNA, and depletion of mtRNA from total RNA abolished its activation. Altogether, our study demonstrates that avoidance of 5'p-RNA recognition is crucial to prevent mtRNA-triggered RIG-I-mediated autoinflammation.

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Address: Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.; Institute of Structural Biology, University Hospital Bonn, Bonn, Germany.; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.; Unit of Experimental Immunology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.